0.13Open0.13Pre Close0 Volume18 Open Interest3.00Strike Price0.00Turnover364.42%IV39.96%PremiumJul 19, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.13Extrinsic Value100Contract SizeAmericanOptions Type-0.1035Delta0.0837Gamma36.77Leverage Ratio-0.0345Theta-0.0001Rho-3.80Eff Leverage0.0011Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet